Mendus AB: Mendus Publishes Preclinical Data Demonstrating Significant Anti-Tumor Synergies of Intratumoral Immune Priming with CTLA-4 Inhibition

What we do
About us
News & events
Investors
Careers

Back
Mendus AB: Mendus Publishes Preclinical Data Demonstrating Significant Anti-Tumor Synergies of Intratumoral Immune Priming with CTLA-4 Inhibition
 8:00:00 AM

Keep reading
Immunicum AB: Immunicum Announces Corporate Rebranding and Name Change to Mendus ABRead